The transport of virulence factors from bacterium to the eukaryotic host cell has emerged as a fundamental strategy in pathogenesis. Several relevant Gram-negative pathogens use type IV secretion systems (T4SS) for 'effector'protein translocation. Coxiella burnetii, a Category B select agent and the causative agent of 'Q'fever is an obligate intracellular vacuolar parasite in vertebrates. After internalization by phagocytes, C.burnetii remodels its vacuole to replicate in a harsh phagolysosomal compartment, likely attributable to the translocation of effector proteins by a T4SS. Due to its obligate intracellular lifestyle, genetic manipulation of C.burnetii remains severely limited. Genomic information revealed however that C.burnetii harbors the genes encoding a T4SS found in Legionella pneumophila called Dot/Icm. Recent studies indicated that expression of C.burnetii (Cb) homologs of the dot/icm components IcmS and IcmW could complement intracellular growth defects of L.pneumophila (Lp) icmS or icmW mutants. We have established that IcmS and IcmW form a complex in the Legionella cytoplasm, and are important for early stages of substrate recognition. The goal of this study is to use L.pneumophila as a surrogate host for the characterization of specific secretion determinants of recently identified effector proteins from C.burnetii. Using molecular, genetic, and biochemical strategies, we will determine secretion signal signatures on Coxiella effector proteins, and define Cb IcmSW binding sites on Cb effectors. Determination of consensus secretion determinants will be applied to systematic computational approaches through the development of new search algorithms to identify novel effector proteins harbored on the C.burnetii genome. Outcomes from these studies will provide novel targets for antimicrobial development to combat critical stages of effector protein recognition and transport by the T4SS.

Public Health Relevance

The Q fever bacterium Coxiella burnetii is an obligate intracellular pathogen whose lifestyle has impeded the development of reliable genetic tractability. We are using Legionella pneumophila, a related bacterium with pathogenic strategies predicted to be conserved, to identify and characterize critical transport determinants on virulence factors. This work will lead to the identification of a new catalog of virulence factors associated with establishment of Q fever, and provide novel targets for antimicrobial development

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21AI088275-01
Application #
7871293
Study Section
Special Emphasis Panel (ZRG1-IDM-A (90))
Program Officer
Perdue, Samuel S
Project Start
2010-05-15
Project End
2012-04-30
Budget Start
2010-05-15
Budget End
2011-04-30
Support Year
1
Fiscal Year
2010
Total Cost
$231,000
Indirect Cost
Name
Oregon Health and Science University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
096997515
City
Portland
State
OR
Country
United States
Zip Code
97239
Li, Jie; Overall, Christopher C; Johnson, Rudd C et al. (2015) ChIP-Seq Analysis of the ?E Regulon of Salmonella enterica Serovar Typhimurium Reveals New Genes Implicated in Heat Shock and Oxidative Stress Response. PLoS One 10:e0138466
Nakayasu, Ernesto S; Sydor, Michael A; Brown, Roslyn N et al. (2015) Identification of Salmonella Typhimurium Deubiquitinase SseL Substrates by Immunoaffinity Enrichment and Quantitative Proteomic Analysis. J Proteome Res 14:4029-38
Millar, Jess A; Valdés, Raquel; Kacharia, Fenil R et al. (2015) Coxiella burnetii and Leishmania mexicana residing within similar parasitophorous vacuoles elicit disparate host responses. Front Microbiol 6:794
Drennan, Samuel L; Lama, Amrita; Doron, Ben et al. (2013) Tractable mammalian cell infections with protozoan-primed bacteria. J Vis Exp :
McDermott, Jason E; Corrigan, Abigail; Peterson, Elena et al. (2011) Computational prediction of type III and IV secreted effectors in gram-negative bacteria. Infect Immun 79:23-32